LONDON, UNITED KINGDOM--(Marketwire - April 08, 2008) - NextGen Bioscience, Inc. (“NextGen”) (PINK SHEETS: NXGB), a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening cancers, today announced it has acquired use, commercialisation and ownership rights of a patent application for the treatment of cancer from Oxon Life Science Inc.
